Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03335007

Pretreatment Aceclofenac Effect on Pain and Analgesic Intake After Endodontic Treatment

Pretreatment Aceclofenac Effect on Pain and Analgesic Intake After Endodontic Treatment: A Randomized, Double-blind, Placebo-controlled Trial

Sponsor: Cairo University

Conditions Symptomatic Irreversible Pulpitis

Interventions Aceclofenac Placebo

Updated 5 times since 2017 Last updated: Nov 6, 2017 Started: May 31, 2015 Primary completion: Jul 31, 2017 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Symptomatic Irreversible Pulpitis and is currently completed. Cairo University leads this study, which shows 5 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Dec 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt